Antiviral Agents

Introduction: All Antiviral Drugs are virustatic
Antiviral Drugs for – Herpes viruses
- remember that these are DNA viruses
- Includes HSV 1&2, VZV, CMV, EBV, HHV-6, HHV-7, HHV-8
Specific Drugs
Acyclovir – guanosine analogue
- requires phosphorylation to triphosphate form for activity
- the viral thymidine kinase performs the initial phosphorylation
- Mechanism
Ø irreversibly binds to viral DNA polymerase
Ø acts as a chain terminator and inhibitor of viral DNA polymerase
- Absorption
Ø bioavailability – 10-20%
Ø CSF levels ~50% that of plasma
- USED FOR: HSV or VZV
- Minimal toxicity
Valaciclovir – guanosine analogue
- PRODRUG of acyclovir
- Increased bioavailability – 50-60%
- Use: VZV, HSV
Famiciclovir – guanosine analogue
- converted to peniciclovir in the intestinal wall and liver
- MOA similar to acyclovir
- Greater bioavailability than acyclovir (75%)
- Penciclovir excreted unchanged in the urine
- Use: VZV, HSV 1 & 2
Ganciclovir – guanosine analogue
- NOT dependent on viral thymidine kinase for initial phosphorylation
- Good CSF penetration
- Use: life threatening CMV disease
- Toxicity: hematologic
Vidarabine – adenosine analogue
- inhibits DNA polymerase; requires phosphorylation
- USE: 1st one for HSV, now others used; Ophthalmic ointment in herpes keratitis
- Toxicity: HIGH DOSES necessary so GI, CNS, hematologic
Cidofovir – nucleotide analogue
- inhibits viral DNA polymerase
- requires phosphorylation to active form
- long intracellular t1/2
- USE: significant CMV disease
- Toxicity: renal toxicity
Phosphonoformate – pyrophosphate analogue
- activity against viral DNA polymerase, reverse transcriptase, and RNA polymerase in vitro
- chain terminator
- USE: acyclovir-resistant HSV or VZV, CMV retinitis
- Toxicity: renal, “metabolic”
Idoxuridine, Trifluridine – thymidine analogues
- phosphorylated by BOTH viral and cellular thymidine kinase
- inhibit BOTH viral and cellular DNA synthesis
- USE: ONLY topically in opthalmic prep – HSV keratitis
Fomivirsen sodium – antisense oligonucleotide
- antisense oligonucleotide complementary to immediate-early region of CMV nuclei acid
- inhibits viral replication
- Use: CMV retinitis; only for injection into the eye
- Toxicity: inflammation, increased intraocular pressure
Antiviral Drugs for Respiratory Viruses
- most are RNA viruses (except adenovirus)
Specific Drugs
Ribavirin – guanosine analogue
- competitive inhibitor of DNA and RNA synthesis; unknown MOA
- administrated via aerosol
- oral an IV available
- USE: Pneumonitis due to RSV
- Toxicity: minimal if aerosolized, anemia in IV and oral use
Amantadine – primary amine
- interferes with the release of viral RNA genome into cell
- Use: prophylaxis and treatment of influenza A
- Also used in Parkinson’s patients
- Toxicity: reversible CNS effects, potentiated by antihistamines
Rimantadine -
- same as amantadine, except fewer CNS side effect
Antiviral Drugs for HIV
Zidovudine (AZT) – thymidine analogue
- inhibits reverse transcriptase and acts as a DNA chain terminator
- HISTORY: 1st line agent for HIV
- Toxicity:
1) hematologic
2) lactic acidosis
3) severe hepatomegaly with steatosis
Didanosine – deoxyadenosine analogue
- RT inhibitor and DNA chain terminator
- Rapidly degraded by acidic pH, must take buffering agent with the oral prep.
- Toxicity
1) pancreatitis
2) peripheral neuropathy
Zalcitabine – deoxycytidine analogue
- RT inhibitor and DNA chain terminator
- Use: 2nd line agent in combo therapy
- Toxicity: peripheral neuropathy
Staduvine – thymidine analogue
- RT inhibitor and DNA chain terminator
- Use: HIV patients intolerant or not responding to alternate therapy
- Toxicity: peripheral neuropathy
Lamivudine – cytidine analogue
- RT inhibitor and DNA chain terminator
- Use in combo therapy – Lamivudine + Zidovudine = Combivir
- Less toxic than other antiretroviral agents; pancreatitis
Abacavir – guanosine analogue
- DNA chain terminator
- Use: combo therapy
- Toxicity: hypersensitivity
Non-Nucleoside RT Inhibitors (NNRTIs)
- Nevirapine
- Delavirdine
- Efavirenz
Ø non-nucleoside inhibitors
Ø directly bind to RT
Ø p450 metabolism
Ø USE: combo therapy
Ø Toxicity: rash, Efavirenz with CNS symptoms
Protease Inhibitors
- Sequinavir
- Ritonavir
- Indinavir
- Nelfinavir
Ø inhibit HIV aspartic protease
Ø results in production of non-infectious virus
Ø p450 metabolism
Ø Use: combo therapy
Ø Toxicity: diabetes mellitus, GI, liver
Interferon and Immunomodulators in Antiviral Therapy
Immunomodulator – diverse group of biologically active compounds which alter the immune response via direct or indirect interactions with T cells, B cells, or APCs.
Interferons – subset of immunomodulators. Family of related peptides, produced by cells in response to viral infection or other stimuli
Specific Drugs
Interferon - a
- mechanism
Ø multiple mechanisms of antiviral activity
- includes activation of enzymes blocking viral transcription and translation
- inactivated in GI tract, thus subQ or injected into lesions
- use: therapy of Hep B and C, papillomavirus
- Toxicity: influenza like symptoms, CNS disorders
Tags: Cidofovir, Famiciclovir, Fomivirsen sodium, Ganciclovir, guanosine analogue, Herpes viruses, Idoxuridine, Phosphonoformate, phosphorylation, Ribavirin, Trifluridine, Valaciclovir, Vidarabine
